The ability to identify abnormalities in the body’s
saccharide
profile is a promising means for early disease detection but requires
analytical tools capable of detecting saccharides at low concentrations
and/or for volume-limited samples. The preferred analysis approach
for these compounds, liquid chromatography–electrospray ionization–mass
spectrometry (LC–ESI–MS), often lacks sensitivity due
to poor ionization efficiency. In this work, we employ a modified
electrospray interface-termed contained-electrospray (contained-ESI)
to couple accelerated droplet chemistry to conventional LC–MS
for the online and automated separation, derivatization, and detection
of saccharides. The chromatographic component enables complex sample
and mixtures analysis with low sample volume requirements, while the
enhanced reaction kinetics afforded by electrosprayed microdroplets
facilitates rapid, on-the-fly derivatization to boost sensitivity.
Derivatization occurs during ion formation as analytes elute from
the column, eliminating the need for superfluous post-column derivatization
hardware or complicated benchtop protocols. A grounded coupler was
incorporated to shield the LC from the high-voltage ion source, and
method conditions were optimized to accommodate the low flow rates
preferred for microdroplet reactions. The new LC-contained-ESI-MS/MS
platform was demonstrated for the analysis of several mono-, di-,
and oligosaccharides using in-source droplet-based phenylboronic acid
derivatization. Femtomole limits of detection were achieved for a
1 μL injection, representing sensitivity enhancement of 1–2
orders of magnitude over conventional LC–ESI–MS/MS without
derivatization. In addition, isobaric saccharides that are difficult
to differentiate by MS alone were easily distinguished. Method precision,
accuracy, and linearity were established, and the ability to detect
oligosaccharides at trace levels in human urine and plasma was demonstrated.